• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Molecular Mysteries in the Blood

Molecular Mysteries in the Blood

by Michael Schubert, PhD | Aug 29, 2024 | Clinical Diagnostics Insider, Emerging Tests-dtet

The current landscape of molecular hematopathology—and what steps clinical labs can take to stay at the forefront of the discipline

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
The Benefits of Group A Streptococcus NAAT

The Benefits of Group A Streptococcus NAAT

by Tyler Radke, MLS(ASCP)CM | Apr 25, 2024 | Essential, Lab Industry Advisor, Operations-lca

Labs that invested heavily in POC molecular tests during COVID-19 are well positioned to leverage this equipment toward GAS diagnostics

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
New Guidelines Recommend Molecular Testing for Pediatric Brain Cancer Treatment

New Guidelines Recommend Molecular Testing for Pediatric Brain Cancer Treatment

by Glenn S. Demby | Aug 26, 2022 | News, Open Content, Special Focus-dtet

For labs, the big takeaway is how prominently molecular testing and profiling figures in so many aspects of the NCCN’s recommendations.

NCI Program Expands Access to Key Diagnostic for Childhood Cancers

NCI Program Expands Access to Key Diagnostic for Childhood Cancers

by Rachel Muenz | Mar 28, 2022 | Articles, News, Open Content

A new initiative launched by the National Institutes of Health’s National Cancer Institute (NCI) on March 21 will bring a state-of-the art diagnostic option to children, adolescents, and young adults who have recently been diagnosed with central nervous system tumors....
New Assay Could ID Best Cancer Treatment Earlier and Faster

New Assay Could ID Best Cancer Treatment Earlier and Faster

by Rachel Muenz | Feb 14, 2022 | Articles, News, Open Content

A recently developed assay could make identifying the best cancer treatment for each patient a quicker and more cost-effective process, compared to current tests. Researchers from the Public Health Research Institute of the New Jersey Medical School of Rutgers...
« Older Entries
Next Entries »

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com